These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1454660)

  • 1. [Proliferation and differentiation of cells and differentiation- inducing treatment in leukemia].
    Kuliczkowski K
    Pol Arch Med Wewn; 1992 Jul; 88(1):49-56. PubMed ID: 1454660
    [No Abstract]   [Full Text] [Related]  

  • 2. All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia.
    Miyauchi J
    Leuk Lymphoma; 1999 Apr; 33(3-4):267-80. PubMed ID: 10221506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.
    Nilsson B
    Br J Haematol; 1984 Jul; 57(3):365-71. PubMed ID: 6589010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth restrictions in the regulation of haemopoiesis.
    Zipori D; Honigwachs-Sha'anani J
    Baillieres Clin Haematol; 1992 Jul; 5(3):741-52. PubMed ID: 1457967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental model for differentiation therapy of leukemia].
    Hayashi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of the proliferative and differentiation capacity of stem cells following treatment with chemical and viral leukemogens.
    Dexter TM; Teich NM
    Haematol Blood Transfus; 1979; 23():223-9. PubMed ID: 544362
    [No Abstract]   [Full Text] [Related]  

  • 9. The proliferative state of normal hemopoietic stem cells during progression of leukemia. Studies in the BN acute myelocytic leukemia (BNML).
    Hagenbeek A; Martens AC
    Leuk Res; 1981; 5(2):141-8. PubMed ID: 6941052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
    Brodzki LM
    Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new pharmacological activity of dibutyl phthalate (DBP) on selective elimination of tumor cells from bone marrow.
    Wu CT; Pei XT; Cao JR; Xue HH
    Leuk Res; 1993 Jul; 17(7):557-60. PubMed ID: 8326736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoplastic transformation of the pluripotential stem cell. II. Regeneration and differentiation of populations of leukemic blast cells].
    Rupniewska ZM
    Acta Haematol Pol; 1985; 16(1-2):102-8. PubMed ID: 3914169
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of murine myeloid leukemia by aclacinomycin-A based on the dynamics of leukemic colony forming unit and normal hematopoietic stem cells.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1324-32. PubMed ID: 6963084
    [No Abstract]   [Full Text] [Related]  

  • 16. [Retinoic acid and 12-0-tetradecanoylphorbol-13-acetate (TPA) inducing bipotent differentiation of cultured primary bone marrow cells from leukemia patients].
    Chen ZX; Wu WL
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):26-9. PubMed ID: 1889336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
    Chen ZX; Wang W; Wu WL
    Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia.
    Imaizumi M; Breitman TR
    Eur J Haematol; 1987 Apr; 38(4):289-302. PubMed ID: 3038598
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
    N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
    [No Abstract]   [Full Text] [Related]  

  • 20. [Induction of differentiation of human leukemia cells].
    Kizaki M; Nakajima H; Ikeda Y
    Hum Cell; 1992 Jun; 5(2):103-9. PubMed ID: 1382572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.